"A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for Wet Age-Related Macular Degeneration"

PHASE3TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2005

Conditions
"Wet Age-Related Macular Degeneration"
Interventions
DRUG

Squalamine Lactate

Trial Locations (29)

10021

MaculaCare, New York

15213

Retina Vitreous Consultants, Pittsburgh

University of Pittsburgh Medical Center, Pittsburgh

17033

Penn State Ophthalmology, Hershey

19462

Genaera Corporation, Plymouth Meeting

20176

Virginia Retina Center, Leesburg

21740

Cumberland Valley Retina Consultants, PC, Hagerstown

28210

Charlotte Eye, Ear, Nose & Throat Associates, Charlotte

28211

Horizon Eye Care, Charlotte

29223

Carolina Retina Center, Columbia

32256

University of Florida, Jacksonville

32803

Magruder Eye Institute, Orlando

33426

Florida Eye Microsurgical Institute, Boynton Beach

33609

Retina Associates of Florida, Tampa

33880

Center for Retina and Macular Disease, Winter Haven

33912

National Ophthalmic Research Institute, Fort Myers

34994

East Florida Eye Institute, Stuart

37660

Southeastern Retina Associates, Kingsport

43210

The Ohio State University, Havener Eye Institute, Columbus

46280

Midwest Eye Institute, Indianapolis

57701

Black Hills Regional Eye Institute, Rapid City

66204

Retina Associates, PA, Shawnee Mission

77002

Garcia & Associates, MD, PA, Houston

78705

Retina Research Center, Austin

80027

Eldorado Retina Associates, Louisville

84132

John Moran Eye Center, Salt Lake City

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

08648

Delaware Valley Retina Associates, Lawrenceville

07666

Retina Associates of New Jersey, Teaneck

Sponsors
All Listed Sponsors
lead

Genaera Corporation

INDUSTRY